Article

Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from Germany

2026-04-02

Abstract excerpt

<title>Abstract</title> <p>Background Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are rare autoimmune disorders. Their true prevalence in Germany is unknown and can only be estimated from heterogeneous international data. Assuming 1–3 cases per 100,000 people for each disease suggests several thousand affected individuals nationwide,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 845444a9-50cd-5ffa-9459-8a5d1cd003e8
DOI: 10.21203/rs.3.rs-9209675/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from GermanyDOI 10.21203/rs.3.rs-9209675/v1Read

Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity Read

From Fragmented Evidence to a Unified GCC Demyelinating Disease Registry: A Strategic Framework for MS, NMOSD, MOGAD, Optic Neuritis, LETM, and Pediatric Acquired DemyelinationSemantic proximity Read

[Clinical features and modern diagnostic criteria of the disease associated with myelin oligodendrocyte glycoprotein antibody disease].Semantic proximity Read

The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.Semantic proximity Read

Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide surveySemantic proximity Read

Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseSemantic proximity Read

MOGAD update: new phenotypes in the expanding clinical spectrum.Semantic proximity Read

Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective studySemantic proximity Read

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.Semantic proximity Read

Differences in clinical features, disease outcomes and imaging features of demyelinating syndrome after MOG antibody therapySemantic proximity Read

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.Semantic proximity Read

Beyond MOG and AQP4 Antibodies: Alternative Causes of Optic NeuritisSemantic proximity Read